Agyany Pharma

Developing treatments for Parkinson's disease, focusing on ambroxol as a pharmacological chaperon for GBA1-related Parkinson's.

Biotechnology
Active
Jerusalem, Israel Founded 2026
Website ↗
Last updated 2026-08-06
Total raised
Stage
Founded
2026
Headcount
HQ
Jerusalem, Israel
Sector
Biotechnology

About

Agyany Pharma is an Israeli biotechnology company developing first-in-class therapies for Parkinson's disease, particularly GBA1-associated Parkinson's (Sidransky Syndrome). The company focuses on repurposing existing generic drugs, such as ambroxol, to target the genetic and molecular drivers of the disease. Their approach is based on decades of research in Gaucher disease and aims to provide novel therapeutic approaches for both GBA-related PD and potentially idiopathic PD.

Funding history · 3 rounds · — total

2020-06
A Round $38.0M
2019-07
Undisclosed Round $319K
★ AG-Bio Center★ Normandie Incubation★ Angel (individual)
2019-02
Seed $8.5M

Team · 8

Prof. Dr. Arndt Rolfs
Founder · Co-Founder and Chairman
Prof. Dr. Ari Zimran
Founder · Co-Founder and Chief Medical Officer
Sivan Frank
Chief Executive Officer
Dr. Aliaksandr Skrahin
Sr. Medical Director
Liana Babchenko Springer
Head of Clinical Trials
Jonathan Arnon
Legal Counsellor
Prof. Mia Horowitz
Staff member
Prof. Dr. Sharon Hassin
Staff member

Sectors & technology

Primary sector
Biotechnology
Technologies
Target customers
Business model
Drug Development
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteagyanypharma.com/

Identifiers & details

Legal nameAgyany Pharma
Founded2026

Radar intelligence

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516706751
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2022-11-14
Purposeלעסוק בסוגי עיסוק שפורטו בתקנון
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens1
Registry events4 — annual_report (1), charge (1), people (2)
Registered addressהדישון 14 ירושלים

Recent registry events

DateEvent
2026-06-29דו~ח שנתי
2026-05-19רישום שעבוד
2026-01-14עדכון בעלי תפקידים
2025-12-03עדכון דירקטורים-הסרת דירקטור